Abstract
In the megaesophagus of Chagas’ disease, chronic esophagitis is caused by stasis of swallowed food and saliva. In this environment, the overgrowth of aerobic and anaerobic bacteria, including nitrate-reducing bacteria, is observed. The reduction of nitrate into nitrite by the action of these bacteria has been associated with the formation of volatile nitrosamines in different situations of gastric bacterial overgrowth. We have hypothesized that this phenomenon could occur in the esophageal lumen of patients with megaesophagus. To evaluate the concentration of nitrite, the presence of volatile nitrosamines and the concentration of nitrate-reducing bacteria in the esophageal lumen of patients with nonadvanced megaesophagus of Chagas’ disease and in a group of patients without esophageal disease. Fifteen patients with nonadvanced megaesophagus [megaesophagus group (MG)] and 15 patients without any esophageal disease [control group (CG)] were studied. Saliva samples were taken for nitrate and nitrite quantitative determination and esophageal stasis liquid samples were taken for nitrate and nitrite quantitative determination, volatile nitrosamines qualitative determination and reductive bacteria quantitative determination. MG and CG were equivalent in nitrate and nitrite saliva concentration and in nitrate esophageal concentration. Significant difference was found in nitrite (p = 0.003) and reductive bacteria concentration (p < 0.0001), both higher in MG. Volatile nitrosamines were identified in three MG patients and in none of the CG patients, but this was not significant (p = 0.113). There is a higher concentration of reductive bacteria in MG, responsible for the rise in nitrite concentration at the esophageal lumen and, eventually, for the formation of volatile nitrosamines.
Similar content being viewed by others
References
Carter R, Brewer LA. Achalasia and esophageal carcinoma: Studies in the early diagnosis for improved surgical management. Am J Surg 1975;130:114–120.
Chuong JJ, Dubovik S, McCallum RW. Achalasia as a risk factor for esophageal carcinoma. Dig Dis Sci 1984;29:1105–1108.
Meijssen MAC, Tilanus HW, Van Blankenstein M, Hop WCJ, Ong GL. Achalasia complicated by esophageal squamous cell carcinoma: A prospective study in 195 patients. Gut 1992;33:155–158.
Peracchia A, Segalin A, Bardini R, Ruol A, Bonavina L. Esophageal carcinoma and achalasia: Prevalence, incidence and results of treatment. Hepato-gastroenterol 1991;38:514–516.
Loviscek LF, Cenoz MC, Badaloni AE, Agarinakazato O. Early cancer in achalasia. Dis Esophagus 1998;11:239–247.
Sandler RS, Nyren O, Ekbom A, Eisen GM, Yuen J, Josefsson S. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA 1995;274:1359–1362.
Yamamuro EM, Cecconello I, Iriya K, Tomishigue T, Oliveira MA, Pinotti HW. Lugol dye endoscopy for analysis of esophageal mucosa in achalasia. Hepato-gastroenterol 1999;46(27):1687–1691.
Pajecki D, Zilberstein B, Santos MAA, Ubriaco JÁ, Quintanilha AG, Cecconello I, Gama-Rodrigues JJ. Megaesophagus microbiota: A qualitative and quantitative analysis. J Gastrointest Surg 2002;6:723–729.
Dallinga JW, Pachen DMFA, Lousberg AHP, Van Geel JAM, Houben GMP, Stockbrugger RW, Van Maanen JMS, Kleijans JCS. Volatile N-nitrosamines in gastric juice of patients with various conditions of the gastrointestinal tract determined by gas chromatography-mass spectrometry and nitrite levels. Cancer Lett 1998;124;119–125.
Ribeiro U Jr, Posner MC, Safatle-Ribeiro AV. Risk factors for squamous cell carcinoma of the esophagus. Br J Surg 1996;3:1174–1185.
Soner GD, Gupt A. Etilogy and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001;22:1737–1746.
Verdu E, Viani F, Amstrong D, Fraser R, Siergrist HH, Pignatelli B, Fried M. Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut 1994;35:455–460.
Vermeer ITM, Danielle MFA, Dallinga JW, Kleijans JCS, Van Maanen JMS. Intragastric volatile N-nitrosamines, nitrite, pH and Helicobacter pylori during long-term treatment with Omeprazole. Gastroenterology 2001;121:517–525.
Rezende JM, Lauar KM, Oliveira AR. Aspectos clínicos e radiológicos da aperistalse do esôfago. Rev Bras Gastroenterol 1960;12:247–262.
Gagliardi D, Makihara S, Corsi PR, de Toledo Viana A, Wiczer MVFS, Nakakubo S, Mímica LMJ. Microbial flora of the normal esophagus. Dis Esophagus 1998;11:248–250.
Van Maanen JMS, Welle IJ, Hageman G, Dallinga JW, Mertens PLJM, Kleijans JCS. Nitrate contamination of drinking water: Relationship with HPRT varian frequency in linphocyte DNA and urinary excretion of N-nitrosamines. Environ Health Perspect 1996a;104:521–528.
Van Maanen JMS, Van Geel AA, Kleinjans JC. Modulation of nitrate–nitrite conversion in the oral cavity. Cancer Detec Prev 1996;20:590–596.
Van Maanen JM, Pachen DM, Dallinga JW, Kleijans JC. Formation of nitrosamines during consumption of nitrate- and amine-rich foods, and the influence of the use of mouthwashes. Cancer Detec Prev 1998;22:204–212.
Acknowledgment
Funding for this study was provided by the Fundação para o Amparo à Pesquisa do Estado de São Paulo.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pajecki, D., Zilberstein, B., Cecconello, I. et al. Larger Amounts of Nitrite and Nitrate-reducing Bacteria in Megaesophagus of Chagas’ Disease than in Controls. J Gastrointest Surg 11, 199–203 (2007). https://doi.org/10.1007/s11605-006-0066-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-006-0066-y